MLTX logo

MoonLake Immunotherapeutics (MLTX) EV/EBITDA

EV/EBITDA:

-1.65-0.13(-8.55%)
October 13, 2025

Summary

  • As of today, MLTX EV/EBITDA is -1.65, with a fall of -0.13 (-8.55%) during the most recent trading session on October 13, 2025.
  • Over the past year, MLTX EV/EBITDA has increased by +22.28 (+93.10%).
  • MLTX EV/EBITDA is now -587.50% below its all-time high of -0.24.

Performance

MLTX EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherMLTXvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

MLTX EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise ValueEnterprise ValuePricePrice
1D1 Day-8.6%+8.4%+3.9%
1M1 Month+89.1%-89.0%-79.7%
3M3 Months+88.1%-88.1%-78.2%
6M6 Months+84.6%-81.9%-69.5%
YTDYTD+92.1%-89.0%-80.3%
1Y1 Year+93.1%-87.4%-78.2%
5Y5 Years---

MLTX EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month-0.24-587.5%-18.08+90.9%
3M3-Month-0.24-587.5%-18.08+90.9%
6M6-Month-0.24-587.5%-18.08+90.9%
1Y1-Year-0.24-587.5%-28.21+94.2%
3Y3-Year-0.24-587.5%-61.99+97.3%
5Y5-Year-0.24-587.5%-1492+99.9%
All-TimeAll-Time-0.24-587.5%-1492+99.9%

MLTX EV/EBITDA History

DateValue
2025
-1.65(+92.1%)
2024
-20.96(+63.9%)
2023
-58.11(-1019.7%)
DateValue
2022
-5.19(-121.8%)
2021
-2.34(+99.8%)
2020
-1333.00

FAQ

  • What is MoonLake Immunotherapeutics EV/EBITDA?
  • What is the all-time high EV/EBITDA for MoonLake Immunotherapeutics?
  • What is MLTX EV/EBITDA year-to-date change?
  • What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?

What is MoonLake Immunotherapeutics EV/EBITDA?

The current EV/EBITDA of MLTX is -1.65

What is the all-time high EV/EBITDA for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high EV/EBITDA is -0.24

What is MLTX EV/EBITDA year-to-date change?

MoonLake Immunotherapeutics EV/EBITDA has changed by +19.31 (+92.13%) since the beginning of the year

What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?

Over the past year, MLTX EV/EBITDA has changed by +22.28 (+93.10%)
On this page